← Back to directory

Ernesto Ayala

Researcher Next ID · RN-043846

Researcher · Medicine

University of North Carolina at Chapel Hill

Chapel Hill, Mexico

Accepting doctoral researchersFunding unknown
Works count
310
Citation count
3,936
H-index
33
i10-index
77

Research interests

Medicine
Hematopoietic Stem Cell Transplantation
Lymphoma Diagnosis and Treatment
Acute Lymphoblastic Leukemia research
Chronic Lymphocytic Leukemia Research
Acute Myeloid Leukemia Research

Publications

  • Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma

    Haematologica · 2022 · 10.3324/haematol.2022.281242

  • A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantation

    Blood Advances · 2021 · 10.1182/bloodadvances.2020003779

  • Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy

    Transplantation and Cellular Therapy · 2021 · 10.1016/j.jtct.2021.04.007

  • Does bridging radiation therapy affect the pattern of failure after CAR T-cell therapy in non-Hodgkin lymphoma?

    Radiotherapy and Oncology · 2021 · 10.1016/j.radonc.2021.11.031

  • Treatment of CSF1R ‐Related Leukoencephalopathy: Breaking New Ground

    Movement Disorders · 2021 · 10.1002/mds.28734

  • Efficacy of Allogeneic Hematopoietic Cell Transplantation in Cutaneous T Cell Lymphoma: Results of a Systematic Review and Meta-Analysis

    Transplantation and Cellular Therapy · 2019 · 10.1016/j.bbmt.2019.08.019

  • Allogeneic Hematopoietic Cell Transplantation Is an Effective Treatment for Blastic Plasmacytoid Dendritic Cell Neoplasm in First Complete Remission: Systematic Review and Meta-analysis

    Clinical Lymphoma Myeloma & Leukemia · 2018 · 10.1016/j.clml.2018.07.295

  • Allogeneic Hematopoietic Cell Transplantation for Aggressive NK Cell Leukemia. A Center for International Blood and Marrow Transplant Research Analysis

    Transplantation and Cellular Therapy · 2017 · 10.1016/j.bbmt.2017.01.082

  • Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T Cell and NK/T Cell Lymphomas: An International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation

    Transplantation and Cellular Therapy · 2017 · 10.1016/j.bbmt.2017.07.027

  • Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative study

    British Journal of Haematology · 2017 · 10.1111/bjh.14954

  • Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation

    British Journal of Haematology · 2016 · 10.1111/bjh.14046

  • Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial

    Blood · 2016 · 10.1182/blood-2015-08-664706

  • Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation

    Transplantation and Cellular Therapy · 2016 · 10.1016/j.bbmt.2016.09.013

  • Early Failure of Frontline Rituximab-Containing Chemo-immunotherapy in Diffuse Large B Cell Lymphoma Does Not Predict Futility of Autologous Hematopoietic Cell Transplantation

    Transplantation and Cellular Therapy · 2014 · 10.1016/j.bbmt.2014.06.036

  • Phase III Randomized Study of Rituximab/Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) Compared With Iodine-131 Tositumomab/BEAM With Autologous Hematopoietic Cell Transplantation for Relapsed Diffuse Large B-Cell Lymphoma: Results From the BMT CTN 0401 Trial

    Journal of Clinical Oncology · 2013 · 10.1200/jco.2012.45.9453

  • Autologous or Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Sensitive Mantle-Cell Lymphoma: Analysis of Transplantation Timing and Modality

    Journal of Clinical Oncology · 2013 · 10.1200/jco.2013.49.2454

  • Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization

    Bone Marrow Transplantation · 2012 · 10.1038/bmt.2012.150

  • A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation

    Haematologica · 2012 · 10.3324/haematol.2012.067140

  • Human immunodeficiency virus (HIV)-negative plasmablastic lymphoma: A single institutional experience and literature review

    Leukemia Research · 2011 · 10.1016/j.leukres.2011.06.023

  • Maximally Tolerated Busulfan Systemic Exposure in Combination with Fludarabine as Conditioning before Allogeneic Hematopoietic Cell Transplantation

    Transplantation and Cellular Therapy · 2011 · 10.1016/j.bbmt.2011.12.584

  • A Randomized Phase II Trial Comparing Tacrolimus and Mycophenolate Mofetil to Tacrolimus and Methotrexate for Acute Graft-versus-Host Disease Prophylaxis

    Transplantation and Cellular Therapy · 2010 · 10.1016/j.bbmt.2010.01.010

  • Sirolimus for treatment of steroid-refractory acute graft-versus-host disease

    Bone Marrow Transplantation · 2009 · 10.1038/bmt.2009.343

  • 5-Azacitidine for myelodysplasia before allogeneic hematopoietic cell transplantation

    Bone Marrow Transplantation · 2009 · 10.1038/bmt.2009.134

  • Two cases of progressive multifocal leukoencephalopathy after allogeneic hematopoietic cell transplantation and a review of the literature

    Bone Marrow Transplantation · 2006 · 10.1038/sj.bmt.1705548

  • Valganciclovir is safe and effective as pre-emptive therapy for CMV infection in allogeneic hematopoietic stem cell transplantation

    Bone Marrow Transplantation · 2006 · 10.1038/sj.bmt.1705341

Current projects

    No projects listed.